Kymera Therapeutics (KYMR) Financials: Revenue & Earnings

KYMR price $122.08 +4.51 +3.84%

Ticker
KYMR
Price
$122.08
Change
+4.51 +3.84%
Market cap ?
$10.04B
P/E ?
-37.21
Dividend yield ?
0.00%
Beta ?
1.98
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
47
Value
32
Quality
30
Growth
78

Stocklytics score rationale: value 32, quality 30, growth 78.

Financials

20182019202020212022202320242025
02934000340340007283200046826000785920004707200039200000

Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various…

Fair value

KYMR fair value Not meaningful. Price $122.08.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare KYMR

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-29—-1.27—3.28M
2026-08-05-0.62-0.7165.00M32.78M
2026-04-30-0.71-0.8934.37M8.27M
2026-02-26-0.97-0.782.87M15.05M
2025-11-04-0.90-0.712.76M14.45M
2025-08-11-0.95-0.8311.48M17.13M
2025-05-09-0.82-0.9222.10M12.38M
2025-02-27-0.88-0.767.39M16.68M
2024-10-31-0.82-0.833.74M15.21M
2024-08-07-0.58-0.6925.65M12.55M
2024-05-02-0.69-0.7310.29M13.69M
2024-02-22-0.25-0.4447.88M41.96M
2023-11-02-0.90-0.734.73M15.97M
2023-08-03-0.67-0.7016.51M14.06M
2023-05-04-0.70-0.699.47M14.15M
2023-02-23-0.60-0.5716.14M22.05M
2022-11-03-0.79-0.709.55M15.51M
2022-08-09-0.78-0.6811.51M14.24M
2022-05-03-0.71-0.679.62M18.75M
2022-02-24-0.66-0.3615.28M21.31M
2021-11-10-0.56-0.3420.34M17.76M
2021-08-06-0.55-0.2118.52M18.52M
2021-05-06-0.29-0.1718.70M15.62M
2021-03-11-0.290.0912.79M—
2020-11-05-0.39-0.2114.53M11.56M
2020-08-21-0.25—3.43M—
2020-06-30-0.32—3.29M—
2019-12-31-0.26—1.83M—
2019-09-30-0.26—950.00K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Mainolfi NelloBuy30.00K$2.0862.40K
2026-10-01Mainolfi NelloSell3.52K$111.44392.83K
2026-10-01Mainolfi NelloSell5.51K$112.42618.98K
2026-10-01Mainolfi NelloSell4.88K$113.24552.16K
2026-10-01Mainolfi NelloSell7.60K$114.43869.78K
2026-10-01Mainolfi NelloSell8.23K$115.40949.74K
2026-10-01Mainolfi NelloSell262$116.1230.42K
2026-10-01Mainolfi NelloSell30.00K$2.0862.40K
2026-09-04Adams BrianSell1.21K$115.55139.70K
2026-09-04Adams BrianSell3.02K$116.81353.35K
2026-09-04Adams BrianSell2.14K$117.57251.25K
2026-07-27Rooney TerenceBuy76.00K$110.058.36M
2026-07-27Rooney TerenceBuy38.00K——
2026-07-27Rooney TerenceOther0——
2026-07-07Mainolfi NelloBuy50.00K$2.08104.00K
2026-07-07Mainolfi NelloSell50.00K$119.005.95M
2026-07-07Mainolfi NelloSell45.56K$2.0894.76K
2026-07-07Mainolfi NelloSell4.44K$2.089.24K
2026-07-01Goodman NoahSell3.39K$114.29387.33K
2026-07-01Mainolfi NelloBuy80.00K$2.08166.40K
2026-07-01Mainolfi NelloSell1.88K$112.80212.41K
2026-07-01Mainolfi NelloSell6.63K$113.98755.20K
2026-07-01Mainolfi NelloSell24.11K$114.962.77M
2026-07-01Mainolfi NelloSell44.05K$115.695.10M
2026-07-01Mainolfi NelloSell3.34K$116.56388.84K
2026-07-01Mainolfi NelloSell80.00K$2.08166.40K
2026-06-30Jacobs Bruce N.Buy61.38K$5.33327.14K
2026-06-30Jacobs Bruce N.Sell1.50K$110.54165.81K
2026-06-30Jacobs Bruce N.Sell1.70K$111.57189.66K
2026-06-30Jacobs Bruce N.Sell1.10K$112.79124.07K
2026-06-30Jacobs Bruce N.Sell4.11K$114.19469.31K
2026-06-30Jacobs Bruce N.Sell51.38K$114.775.90M
2026-06-30Jacobs Bruce N.Sell7.97K$115.82923.18K
2026-06-30Jacobs Bruce N.Sell6.15K$116.99719.86K
2026-06-30Jacobs Bruce N.Sell3.20K$117.70376.65K
2026-06-30Jacobs Bruce N.Sell61.38K$5.33327.14K
2026-06-29Booth BruceSell5.55K$105.78586.97K
2026-06-29Booth BruceSell14.80K$106.631.58M
2026-06-29Booth BruceSell19.42K$107.762.09M
2026-06-29Booth BruceSell10.85K$108.281.17M
2026-06-29Booth BruceSell7.97K$109.75874.49K
2026-06-29Booth BruceSell7.72K$110.67854.70K
2026-06-29Booth BruceSell934$111.20103.86K
2026-06-29Booth BruceSell770$105.7881.45K
2026-06-29Booth BruceSell2.13K$106.63227.44K
2026-06-29Booth BruceSell2.70K$107.76290.74K
2026-06-29Booth BruceSell1.50K$108.28162.20K
2026-06-29Booth BruceSell1.10K$109.75121.16K
2026-06-29Booth BruceSell1.08K$110.67119.30K
2026-06-29Booth BruceSell130$111.2014.46K
2026-06-29Booth BruceSell10.66K$108.281.15M
2026-06-29Booth BruceSell7.83K$109.75859.67K
2026-06-29Booth BruceSell7.60K$110.67841.31K
2026-06-29Booth BruceSell907$111.20100.86K
2026-06-29Booth BruceSell1.69K$108.28182.78K
2026-06-29Booth BruceSell1.24K$109.75135.98K
2026-06-29Booth BruceSell1.20K$110.67132.69K
2026-06-29Booth BruceSell157$111.2017.46K
2026-06-29Booth BruceSell5.47K$105.78578.72K
2026-06-29Booth BruceSell14.61K$106.631.56M
2026-06-29Booth BruceSell19.09K$107.762.06M
2026-06-29Booth BruceSell848$105.7889.70K
2026-06-29Booth BruceSell2.32K$106.63247.17K
2026-06-29Booth BruceSell3.02K$107.76325.87K
2026-06-26Booth BruceSell28.30K$107.573.04M
2026-06-26Booth BruceSell231.01K$108.1424.98M
2026-06-26Booth BruceSell32.62K$109.793.58M
2026-06-26Booth BruceSell11.28K$110.491.25M
2026-06-26Booth BruceSell10.37K$111.511.16M
2026-06-26Booth BruceSell555$112.4962.43K
2026-06-26Booth BruceSell14.91K$113.971.70M
2026-06-26Booth BruceSell27.95K$114.943.21M
2026-06-26Booth BruceSell6.82K$115.69789.12K
2026-06-26Booth BruceSell12.18K$117.091.43M
2026-06-26Booth BruceSell22.05K$117.852.60M
2026-06-26Booth BruceSell12.39K$118.661.47M
2026-06-26Booth BruceSell3.96K$107.57425.76K
2026-06-26Booth BruceSell32.40K$108.143.50M
2026-06-26Booth BruceSell4.56K$109.79500.86K
2026-06-26Booth BruceSell1.58K$110.49174.46K
2026-06-26Booth BruceSell1.44K$111.51160.80K
2026-06-26Booth BruceSell78$112.498.77K
2026-06-26Booth BruceSell2.08K$113.97237.40K
2026-06-26Booth BruceSell3.90K$114.94447.81K
2026-06-26Booth BruceSell952$115.69110.14K
2026-06-26Booth BruceSell1.70K$117.09199.17K
2026-06-26Booth BruceSell3.07K$117.85361.68K
2026-06-26Booth BruceSell1.73K$118.66205.16K
2026-06-26BVF PARTNERS L P/ILSell837.91K$106.5089.24M
2026-06-26BVF PARTNERS L P/ILSell627.60K$106.5066.84M
2026-06-26BVF PARTNERS L P/ILSell113.29K$106.5012.07M
2026-06-26BVF PARTNERS L P/ILSell51.86K$106.505.52M
2026-06-25Booth BruceSell37.18K$119.714.45M
2026-06-25Booth BruceSell112.30K$120.6613.55M
2026-06-25Booth BruceSell40.77K$121.384.95M
2026-06-25Booth BruceSell4.98K$122.67610.53K
2026-06-25Booth BruceSell10.86K$123.621.34M
2026-06-25Booth BruceSell11.71K$124.611.46M
2026-06-25Booth BruceSell3.72K$125.82467.55K
2026-06-25Booth BruceSell1.61K$126.71203.88K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 293, holders +30 vs prior quarter. Ownership 100.01%.

HolderSharesChangeChange %Value
FMR LLC12.35M649.31K+5.55%1.42B
BAKER BROS. ADVISORS LP8.66M00.00%992.73M
AVORO CAPITAL ADVISORS LLC7.47M00.00%857.13M
PRICE T ROWE ASSOCIATES INC /MD/7.11M1.05M+17.36%815.65M
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.6.26M792.26K+14.50%717.52M
BLACKROCK, INC.5.54M477.33K+9.43%635.07M
BVF INC/IL3.87M-1.63M-29.63%444.01M
WELLINGTON MANAGEMENT GROUP LLP3.68M-214.66K-5.52%421.42M
VANGUARD PORTFOLIO MANAGEMENT LLC2.99M118.14K+4.11%343.11M
SIREN, L.L.C.2.94M-251.00K-7.88%336.65M
VANGUARD CAPITAL MANAGEMENT LLC2.93M52.05K+1.81%336.26M
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC2.85M-1.73M-37.80%326.53M
STATE STREET CORP2.74M347.46K+14.54%313.88M
GEODE CAPITAL MANAGEMENT, LLC1.82M170.98K+10.39%208.32M
CAPITAL RESEARCH GLOBAL INVESTORS1.39M-284.39K-17.00%159.26M
GOLDMAN SACHS GROUP INC1.19M298.92K+33.65%136.15M
UBS GROUP AG1.01M-16.07K-1.57%115.56M
DRIEHAUS CAPITAL MANAGEMENT LLC919.23K-124.35K-11.92%105.41M
MERCK & CO., INC.772.16K00.00%88.54M
NORGES BANK757.25K757.25KNew86.83M
FEDERATED HERMES, INC.749.40K212.72K+39.64%85.93M
DIMENSIONAL FUND ADVISORS LP745.15K152.27K+25.68%85.42M
FRONTIER CAPITAL MANAGEMENT CO LLC740.87K-18.98K-2.50%84.96M
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC736.87K-139.01K-15.87%84.50M
ALLIANCEBERNSTEIN L.P.981.52K93.49K+10.53%81.75M

Earnings and financials

Kymera Therapeutics, Inc. (KYMR) trades at $122.08, with a market cap of $10.04B and a trailing P/E of -37.21. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

20182019202020212022202320242025
02934000340340007283200046826000785920004707200039200000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Kymera Therapeutics (KYMR) Financials: Revenue & Earnings

KYMR$122.08+4.51 +3.84%

$10.04B

Market Cap

-37.21

P/E

—

Forward P/E

47

Score

Price History